Endophytes are microbes that colonize the internal tissues of plants without causing any immediate overt negative effects.1 They are considered as a promising source of new natural drug leads that are of great potential for medicinal and agricultural applications.2, 3 For instance, many of the products currently used for human or animal therapy, in animal husbandry and in agriculture, are produced by microbial products, or are derived from them.4 Furthermore, with the increasing incidence of drug resistance in human pathogenic bacteria, which are among the major causes of deaths worldwide,5, 6 there is an urgent need for new bioactive secondary metabolites.

As part of our ongoing research focused on the discovery of new bioactive natural products from endophytic fungi,7, 8 we studied the chemical constituents of the strain Talaromyces wortmanii, which was isolated from healthy tissues of Aloe vera collected in Alexandria, Egypt. Fungi of the genus Talaromyces have been found in solitary, as well as endophytic states in various climates worldwide from terrestrial to marine-influenced environment.9 This genus has been investigated by many researchers as it produces a plethora of interesting compounds such as tetraene lactones,9 diphenyl ether derivatives and anthraquinones,10 which show various biological activities ranging from antibiotics to cytotoxins.9, 10, 11 In the present study, we report the isolation and structure elucidation of a new atropisomer (1) a new wortmannin derivative (2) and two wortmannin derivatives (3-4) that were hitherto known only as synthetic products, as well as seven known metabolites (5-11). Furthermore, we evaluated the antibiotic activity of the isolated compounds against several pathogenic Gram positive and negative bacteria.

The endophytic fungus was isolated from healthy inner tissues of Aloe vera and then identified as T. wortmanii according to a molecular biological protocol by DNA amplification and sequencing of the ITS region. The fungal strain was cultured on rice medium for 4 weeks and then extracted with EtOAc to give 5 g of extract, which was fractionated by vacuum liquid chromatography with n-hexane, n-hexane/EtOAc, CH2Cl2 and CH2Cl2/MeOH gradient elution. Obtained fractions were separated by Sephadex LH-20 using MeOH as solvent system, and the compounds (1-11) (Scheme 1) were finally purified by semi-preparative HPLC.

Compound 1 was obtained as an orange amorphous powder. It showed UV absorption maxima identical to those of emodin.12 ESIMS data of 1 showed a base peak at m/z 537.3 [M-H] (−ve), which inferred that 1 has a MW of 538 g mol−1. The molecular formula was established as C30H18O10 based on the prominent signals detected at m/z 539.0971 [M+H]+ and 561.0787 [M+Na]+ (+ve) in the HRESIMS. In contrast, the 13C NMR data of 1 (Table 1) showed signals corresponding to 15 carbons only, indicating that 1 is a symmetrical dimer consisting of two identical monomers. 1H NMR showed proton signals of one aromatic methyl group resonating at δH 2.49 p.p.m., one aromatic singlet at δH 7.47 p.p.m. and two aromatic broad singlets resonating at δH 7.17 and 7.62 p.p.m. The 13C NMR data (Table 1) exhibited 15 carbon peaks attributable to one methyl group, three methine carbons and 11 quaternary carbon atoms. Further analysis of the 13C spectrum disclosed signals for two carbonyl groups resonating at δC 186.0 (C-9/9′) and 182.0 (C-10/10′), three oxygenated aromatic carbon atoms at δC 164.0 (C-1/1′), 156.0 (C-6/6′) and 163.5 (C-8/8′) and nine aromatic carbons at δC 124.9 (C-2/2′), 150.0 (C-3/3′), 121.5 (C-4/4′), 134.2 (C-4a/4a′), 109.0 (C-5/5′), 114.1 (C-7/7′), 110.1 (C-8/8a′), 115.0 (C-9a/9a′) and δC 137.0 (C-10a/10a′). Comparison of NMR data and UV spectra of 1 with those of emodin, as well as consideration of the MW, suggested that 1 is a symmetrical dimer of two emodin units. The linkage between the emodin building blocks was confirmed by 2D NMR analysis, including 1H–1H COSY and J2/J3 HMBC correlations (Supplementary Figure S1). 1H–1H COSY spectrum showed that the aromatic methyl signal correlated to the meta-coupled protons H-2 and H-4. The absence of the second set of meta-coupled protons and the presence of one aromatic singlet in 1 compared with emodin, confirmed the previous assumption and indicated either a 5,5′- or a 7,7′-linkage of the two emodin moieties. Inspection of the HMBC spectrum showed that CH3-11 correlated to C-2, C-3 and C-4, and the aromatic singlet proton observed at δH 7.47 p.p.m. together with H-4/4′ showed strong J3 correlations to the carbonyl carbons C-10/10′ (Supplementary Figure S1). Thus, the protons resonating at δH 7.47 p.p.m. were assigned to H-5/5′ and a 7,7′-linkage was established. Furthermore, comparison with NMR data of structurally related anthranoids, isolated in our previous studies,7, 8, 12 revealed that in such systems the two meta-coupled aromatic protons H-5/5′ and H-7/7′ resonate at considerably different chemical shifts with H-5/5′ consistently appearing more downfield than H-7/7′ (ca. 7.0< δH <7.2). In addition, a 5,5′-linkage between the two emodin moieties forms the known skyrin,13 which was likewise isolated from T. wortmanii in this study. Accordingly, the 7,7′-linkage of the emodin building blocks to form the new atropisomer 1 was unambiguously confirmed. Compound 1 is an atropisomer resulting from hindered rotation of two symmetrical moieties (emodin) around the biaryl axis, thus the axial chirality was determined by a CD experiment. The CD spectrum exhibited a positive Cotton effect at shorter wavelength and a negative one at longer wavelength, which is typical for the M-conformer (also known as ‘A-type’ or aR). This was also in agreement with the [α]D value of -156. Accordingly, 1 is a new natural product consisting of two emodin moieties, for which the name biemodin is proposed.

Table 1 NMR spectroscopic data of 1 and 2 at 600 (1H) and 150 (13C) MHz (CDCl3)

Compound 2 was obtained as a light brown amorphous powder with UV absorption maxima resembling those of wortmannin (5), likewise isolated during this study. The HRESIMS exhibited a prominent peak at m/z 387.1436 [M+H]+ (+ve), with a 42 mass unit decrease compared with the MW of 5, which established the molecular formula C21H22O7 for 2. Comparison of the 1H NMR spectra of 2 and 5 showed a close relationship between both compounds, except for the presence of an additional hydroxyl group and the absence of the O-acetyl group in 2. Further analysis of 2D NMR data of 2 and 5 confirmed that both share similar skeletons and substituents, except for the replacement of the acetyl function in 5 by an aliphatic methoxy group and the presence of a free hydroxyl group at C-2 in 2 (Supplementary Figure S2). In analogy to 5, three spin systems, including CH(1)CH2(2)OH, CH2(12)CH(11) and CH2(16)CH2(15)CH(14) were detected in the 1H–1H COSY spectrum of 2. In addition, the HMBC spectrum confirmed the assignments of these spin systems. In contrast to 5, the signal of the aliphatic methoxy group of 2 exhibited a strong J3 HMBC correlation to a carbon resonating at δC 53.7 p.p.m. which was attributed to C-11. Hence, CH2-2 is connected to the additional free hydroxyl group, whereas the methoxy group is attached to C-11. Thus, the planar structure of 2 was accomplished. The relative configuration of 2 was deduced from analysis of the coupling constants and comparison to those of 5. Furthermore, comparison of the [α]D values of 2 (+18.8) and 5 (+44) and biogenetic considerations suggest that both compounds share the same absolute configuration. Accordingly, 2 was identified as a new wortmannin derivative for which the name wortmannin B is proposed.

Compound 3-11 were identified on the basis of their 1H and 13C NMR, mass spectrometric data, [α]D values and comparison with published data as amino adduct 3a (3),14 wortmannin-diol (VIII) (4),15 wortmannin (5),15 wortmin (6),16 emodic acid (7),17 skyrin (8),13 oxyskyrin (9),18 rugulosin A (10) and B (11).19 We report here the complete NMR data (1H, 13C, DEPT, COSY, HMBC, HMQC and ROESY, Supplementary Figures S11 to S24) for compounds 3 and 4 for the first time.

All compounds, except 7 and 9 due to their small amounts, were tested for their antibiotic activity against pathogenic Gram negative bacteria, including Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa, Acinetobacter baumannii, Enterobacter sp. and Enterococcus cloacae and Gram positive bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA), Staphylococcus epidermidis, Streptococcus pneumonia, and Enterococcus faecalis (Supplementary Table S3). Among the tested compounds, 8 and 10 exhibited considerable antibiotic activity against Gram positive pathogenic bacteria with MIC values ranging between 4 and 16 μg ml−1. The new biemodin (1) also showed strong activity against Gram positive bacteria, especially against MRSA, but was less active compared to compounds 8 and 10.

Biemodin (1): orange amorphous powder. [α]20D-156 (c 0.02, CHCl3). UV: λmax (PDA)=223, 255, 291 and 450 nm. CD (CHCl3, c=3.71 10–3 M): λmax (Δɛ)=263 (0.624), 291 (–1.80), 316 (–1.59), 374 (–1.08), 470 (–2.94), 507 (–2.38). ESIMS (−ve): m/z=537.3 [M-H]. HRESIMS: calcd. for C30H19O10 [M+H]+ 539.0978; found 539.0971 [M+H]+ and for C30H18O10Na [M+Na]+ 561.0798; found 561.0787. 1H and 13C NMR data, see Table 1.

Wortmannin B (2): light brown amorphous powder. [α]20D+18.8 (c 0.02, MeOH). UV: λmax (PDA)=210, 259 and 300 nm. ESIMS (+ve): m/z=386.8 [M+H]+ and 794.9 [2M+Na]+; (−ve ): m/z 385.0 [M-H] and 770.8 [2M-H]. HRESIMS: calcd. for C21H23O7 [M+H]+ 387.1444; found 387.1436. 1H NMR data, see Table 1.

scheme 1

Structures of isolated compounds.